Insider · CIK 0001818261

Catinazzo Thomas

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001818261

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.5K sh	$18.58	−$325K	105,340
2026-10-06	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−206 sh	$19.26	−$3,967.56	105,134
2026-09-08	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$18.94	−$336K	122,851
2026-08-14	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$19.74	−$350K	140,568
2026-07-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,459 sh	$18.61	−$27.2K	158,285
2026-07-06	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$18.69	−$331K	159,744
2026-06-22	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−51.6K sh	—	—	223,440
2026-06-22	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−51.6K sh	$16.97	−$875K	177,461
2026-06-22	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+61.6K sh	$5.22	+$321K	239,024
2026-06-22	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+51.6K sh	$4.45	+$229K	229,021
2026-06-22	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−61.6K sh	—	—	0
2026-06-22	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−56.3K sh	$16.97	−$956K	177,461
2026-06-22	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−56.3K sh	—	—	0
2026-06-22	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+56.3K sh	$5.04	+$284K	233,784
2026-06-22	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$17.01	−$301K	177,461
2026-06-22	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−61.6K sh	$16.97	−$1.04M	177,461
2026-05-14	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$12.86	−$228K	195,178
2026-04-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−972 sh	$14.79	−$14.4K	212,895
2026-04-09	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,800 sh	$15.00	−$27K	213,867
2026-04-09	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,800 sh	—	—	61,563
2026-04-09	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,800 sh	$5.22	+$9,396	215,667
2026-04-07	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$13.01	−$230K	213,867
2026-03-09	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−17.7K sh	$10.06	−$178K	231,584
2026-01-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,695 sh	$8.45	−$14.3K	249,301
2026-01-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−13.8K sh	$7.62	−$105K	250,996
2026-01-13	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+400K sh	—	—	400,000
2025-10-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−21.7K sh	$7.29	−$158K	313,631
2025-07-29	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−18.4K sh	$3.68	−$67.6K	335,295
2025-07-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,701 sh	$3.74	−$6,361.74	353,675
2025-04-30	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−12.9K sh	$3.00	−$38.8K	355,376
2025-04-29	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,558 sh	$3.23	−$11.5K	368,319
2025-04-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,709 sh	$3.17	−$5,417.53	372,858
2025-04-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−981 sh	$3.17	−$3,109.77	371,877
2025-03-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,566 sh	$2.84	−$13K	374,567
2025-03-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−298 sh	$2.84	−$846.32	379,133
2025-01-30	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−20.8K sh	$4.42	−$91.9K	379,431
2025-01-29	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,109 sh	$4.55	−$9,595.95	400,222
2025-01-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,283 sh	$4.63	−$10.6K	263,190
2025-01-28	RLAYRelay Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+139K sh	—	—	402,331
2025-01-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−33.8K sh	$4.63	−$156K	265,473
2025-01-10	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+275K sh	—	—	275,000
2024-12-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,566 sh	$4.42	−$20.2K	299,226
2024-12-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−299 sh	$4.38	−$1,309.62	303,792
2024-10-29	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,300 sh	$5.95	−$13.7K	304,091
2024-10-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−5,105 sh	$6.06	−$30.9K	306,391
2024-10-28	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,697 sh	$6.06	−$10.3K	311,496
2024-09-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−6,162 sh	$7.46	−$46K	313,193
2024-09-27	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−295 sh	$7.51	−$2,215.45	319,355
2024-07-29	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−9,078 sh	$8.51	−$77.3K	319,650
2024-07-29	RLAYRelay Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,702 sh	$8.85	−$15.1K	328,728

Recent filings

Accepted (ET)
Oct 8 17:294
Catinazzo Thomas0001193125-26-418094
SEC(opens sec.gov)
Sep 94
Catinazzo Thomas0001193125-26-386464
SEC(opens sec.gov)
Aug 184
Catinazzo Thomas0001193125-26-355493
SEC(opens sec.gov)
Jul 304
Catinazzo Thomas0001193125-26-326144
SEC(opens sec.gov)
Jul 84
Catinazzo Thomas0001193125-26-298679
SEC(opens sec.gov)
Jun 244
Catinazzo Thomas0001193125-26-281061
SEC(opens sec.gov)
May 144
Catinazzo Thomas0001193125-26-224545
SEC(opens sec.gov)
Apr 304
Catinazzo Thomas0001193125-26-197419
SEC(opens sec.gov)
Apr 94
Catinazzo Thomas0001193125-26-150044
SEC(opens sec.gov)

Companies

Relay Therapeutics, Inc.Chief Financial OfficerRLAY

Address

C/O RELAY THERAPEUTICS, INC. 60 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139